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1. Introduction {#sec1}
===============

In ([@bib8]) it is reported that transmission of COVID-19 infection may occur from an infectious individual, who is not yet symptomatic. In ([@bib9]) it is reported that COVID-19 infected individuals generally develop symptoms, including mild respiratory symptoms and fever, on an average of 5--6 days after infection (mean 5--6 days, range 1--14 days). In ([@bib13]) it is reported that the median time prior to symptom onset is 3 days, the shortest 1 day, and the longest 24 days. It is evident that these time periods play an important role in understanding COVID-19 transmission dynamics. (see [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"})Table 1Parameters and initial conditions of the model **SEIRU**.Table 1SymbolInterpretationMethod$t_{0}$Time at which the epidemic startedfitted$S_{0}$Number of susceptible at time $t_{0}$fixed$E_{0}$Number of asymptomatic and noninfectious at time $t_{0}$fitted$I_{0}$Number of asymptomatic but infectious at time $t_{0}$fitted$U_{0}$Number of unreported symptomatic infectious at time $t_{0}$fitted.Transmission ratefitted*N*First day of the public interventionsfitted*μ*Intensity of the public interventionsfitted$1/\alpha$average duration of the exposed noninfectious periodfitted$1/\nu$Average time during which asymptomatic infectious are asymptomaticfixed*f*Fraction of asymptomatic infectious that become reported symptomatic infectiousfixed$\nu_{1} = f\ \nu$Rate at which asymptomatic infectious become reported symptomaticfitted$\nu_{2} = \left( {1 - f} \right)\ \nu$Rate at which asymptomatic infectious become unreported symptomaticfitted$1/\eta$Average time symptomatic infectious have symptomsfixedTable 2Cumulative daily reported case data from January 19, 2020 to March 18, 2020, reported for mainland China by the National Health Commission of the People\'s Republic of China and the Chinese CDC ([@bib1]). The data corresponds to cumulative reported cases confirmed by testing.Table 2January19202122232425198291440571830128719752627282930312744451559747711969211791**February**123456714380172052043824324280183116134546891011121314371984017142638446534647248467499701516171819202151091$70548 - 17409$$72436 - 17409$$74185 - 17409$$75002 - 17409$$75891 - 17409$$76288 - 17409$22232425262728$76936 - 17409$$77150 - 17409$$77658 - 17409$$78064 - 17409$$78497 - 17409$$78824 - 17409$$79251 - 17409$29$79824 - 17409$**March**1234567$80026 - 17409$$80151 - 17409$$80270 - 17409$$80409 - 17409$$80552 - 17409$$80651 - 17409$$80695 - 17409$891011121314$80735 - 17409$$80754 - 17409$$80778 - 17409$$80793 - 17409$$80813 - 17409$$80824 - 17409$$80844 - 17409$15161718$80860 - 17409$$80881 - 17409$$80894 - 17409$$80928 - 17409$Table 3Table of the Median Absolute Deviation of model **SEIRU** and **SEIRU**δ.Table 3ODEDDEFigure$\text{MAD}_{ODE}$Figure$\text{MAD}_{DDE}$[Fig. 4](#fig4){ref-type="fig"} (a)1717[Fig. 6](#fig6){ref-type="fig"} (a)662[Fig. 4](#fig4){ref-type="fig"} (b)1251[Fig. 6](#fig6){ref-type="fig"} (b)796[Fig. 4](#fig4){ref-type="fig"} (c)1899[Fig. 6](#fig6){ref-type="fig"} (c)1095[Fig. 4](#fig4){ref-type="fig"} (d)1485[Fig. 6](#fig6){ref-type="fig"} (d)1967[Fig. 5](#fig5){ref-type="fig"} (a)893[Fig. 7](#fig7){ref-type="fig"} (a)178[Fig. 5](#fig5){ref-type="fig"} (b)572[Fig. 7](#fig7){ref-type="fig"} (b)485[Fig. 5](#fig5){ref-type="fig"} (c)754[Fig. 7](#fig7){ref-type="fig"} (c)585[Fig. 5](#fig5){ref-type="fig"} (d)713[Fig. 7](#fig7){ref-type="fig"} (d)852

In this work, we will examine the latency period of COVID-19 infection, that is, the period of time in which newly infected individuals are asymptomatic and noninfectious. We illustrate the latency period in [Fig. 1](#fig1){ref-type="fig"} below:Fig. 1Key time periods of COVID-19 infection. The latent or exposed period before symptoms and transmissibility, the incubation period before symptoms appear, the symptomatic period, and the transmissibility period, which may overlay the asymptomatic period.Fig. 1

In the present article we develop two mathematical models to study the impact of the latency period. One is a ODE (ordinary differential equations) model, with an exposed class of infected individuals, who are not yet infectious. The other is a DDE (delay differential equations) model, with a time delay in newly infected individuals, before they become infectious. The DDE model can be derived from a continuous age of infection model, which can be reduced to a system of DDE. The derivation of such models is described in ([@bib6]). We refer to ([@bib10]; [@bib13]) for early models with exposure applied to COVID-19.

As mentioned in ([@bib5]), asymptomatic infectious cases are not usually reported to medical authorities, and reported infectious cases are typically only a fraction of the total number of the symptomatic infectious individuals. In this work, we examine the number of asymptomatic infectious cases and unreported infectious cases, as well as the number of reported infectious cases, for the COVID epidemic in mainland China. We note that public measures in China, beginning January 26, strongly attenuated the epidemic. One of our objectives is to understand how these measures, such as isolation, quarantine, and public closings, reduce the final size of the epidemic. We examine how the latency period, tied contact tracing and to a 14-day medical observation or quarantine period for exposed persons, mitigates the final size of the epidemic.

2. Models {#sec2}
=========

2.1. Model with a compartment *E* of exposed infected individuals not yet infectious {#sec2.1}
------------------------------------------------------------------------------------

This model has a compartment in the system of ODE that corresponds to exposed or latent infected individuals. We will designate this model as the **SEIRU** model:$$\begin{cases}
{S'\left( t \right) = - \tau\left( t \right)S\left( t \right)\left\lbrack I\left( t \right) + U\left( t \right) \right\rbrack,\ \ \ \ \ \ \ \ \ \ \ \ \ \ } & \\
{E'\left( t \right) = \tau\left( t \right)S\left( t \right)\left\lbrack I\left( t \right) + U\left( t \right) \right\rbrack - \alpha E\left( t \right)} & \\
{I'\left( t \right) = \alpha E\left( t \right) - \nu I\left( t \right)\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } & \\
{R'\left( t \right) = \nu_{1}I\left( t \right) - \eta R\left( t \right)\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } & \\
{U'\left( t \right) = \nu_{2}I\left( t \right) - \eta U\left( t \right).\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } & \\
\end{cases}$$

Here $t \geq t_{0}$ is time in days, $t_{0}$ is the beginning date of the epidemic, $S\left( t \right)$ is the number of individuals susceptible to infection at time *t*, $E\left( t \right)$ is the number of asymptomatic noninfectious individuals at time *t*, $I\left( t \right)$ is the number of asymptomatic but infectious individuals at time *t*, $R\left( t \right)$ is the number of reported symptomatic infectious individuals at time *t*, and $U\left( t \right)$ is the number of unreported symptomatic infectious individuals at time *t*. This system is supplemented by initial data$$S\left( t_{0} \right) = S_{0} > 0,\ E\left( t_{0} \right) = E_{0} > 0,\ I\left( t_{0} \right) = I_{0} > 0,\ U\left( t_{0} \right) = U_{0} > 0,R\left( t_{0} \right) = R_{0} = 0.$$

The exit flux of the exposed class *E* is describe by the term $- \alpha E\left( t \right)$. The means that the time of exposure follows an exponential law, and the average value of the exposure time is $1/\alpha$, which can be, for example, 6 h, 12 h, 1 day, 2 days, 3 days, etc .... The model contains an asymptomatic infectious class corresponding to the $I\left( t \right)$-equation. The dynamics of the symptomatic infectious individuals are decomposed into the $R\left( t \right)$-equation, which corresponds to the reported symptomatic infectious individuals (symptomatic infectious with severe symptoms), and the $U\left( t \right)$-equation, which corresponds to the unreported symptomatic infectious individuals (symptomatic infectious with mild symptoms). The flux of individuals leaving the class *I* is $\nu I\left( t \right)$. We assume that a fraction *f* are reported and a fraction $1 - f$ are unreported. Thus, $\nu_{1} = f\nu\text{~and~}\nu_{2} = \left( {1 - f} \right)\nu.$

The time-dependent parameter $\tau\left( t \right)$ is the transmission rate. During the early phase of the epidemic, when the cumulative number of reported cases grows approximately exponential, . is a constant value $\tau_{0}$. After January 23, strong government measures in all of China, such as isolation, quarantine, and public closings, strongly impacted the transmission of new cases. The actual effects of these measures were complex, and we use a time-dependent exponentially decreasing transmission rate $\tau\left( t \right)$ to incorporate these effects after the early exponentially increasing phase. The formula for $\tau\left( t \right)$ during the exponential decreasing phase is derived by a fitting procedure to the data:$$\begin{cases}
{\tau\left( t \right) = \tau_{0},\ 0 \leq \ t\  \leq \ N,\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } & \\
{\tau\left( t \right) = \tau_{0}\ \text{exp}\left( {- \mu \times \left( {t - N} \right)} \right),\ N < t.} & \\
\end{cases}$$

Day *N* corresponds to the day when the public measures take effect, and *μ* is the rate at which they take effect. A schematic diagram of the model is given in [Fig. 2](#fig2){ref-type="fig"}, and the parameters of the model are listed in [Table 2.1](#tbl2){ref-type="table"} below (see [Fig. 3](#fig3){ref-type="fig"}).Fig. 2Flow chart for the model **SEIRU**.Fig. 2Fig. 3Flow chart for the model **SEIRU***δ.*Fig. 3

2.2. Model with a constant time delay *δ* in the *I* class equation {#sec2.2}
-------------------------------------------------------------------

This model has a time delay *δ* in the $I\left( t \right)$ equation in the system of DDE that contains the latency period. We will designate this model as the **SEIRU***δ* model:$$\begin{cases}
{S'\left( t \right) = - \tau\left( t \right)S\left( t \right)\left\lbrack I\left( t \right) + U\left( t \right) \right\rbrack,} & \\
{I'\left( t \right) = \tau\left( {t - \delta} \right)S\left( {t - \delta} \right)\left\lbrack I\left( {t - \delta} \right) + U\left( {t - \delta} \right) \right\rbrack - \nu I\left( t \right)} & \\
{R'\left( t \right) = \nu_{1}I\left( t \right) - \eta R\left( t \right)} & \\
{U'\left( t \right) = \nu_{2}I\left( t \right) - \eta U\left( t \right).} & \\
\end{cases}$$

This system is supplemented by initial data$$S\left( {t_{0} + \theta} \right) = S_{0}\left( \theta \right) > 0,\ I\left( {t_{0} + \theta} \right) = I_{0}\left( \theta \right) > 0,\ U\left( {t_{0} + \theta} \right) = U_{0}\left( \theta \right) > 0,\forall\theta \in \left\lbrack - \delta,0 \right\rbrack,\text{~and~}R\left( t_{0} \right) = 0.$$

In the model **SEIRU***δ*, the duration of exposure is constant and equal to *δ*. The exposed class is given by the integral formula$$E\left( t \right) = \int_{t - \delta}^{t}\tau\left( \sigma \right)S\left( \sigma \right)\left\lbrack I\left( \sigma \right) + U\left( \sigma \right) \right\rbrack d\sigma.$$or alternatively, by using the differential equation$$E\text{'}\left( t \right) = \tau\left( t \right)S\left( t \right)\left\lbrack I\left( t \right) + U\left( t \right) \right\rbrack - \tau\left( {t - \delta} \right)S\left( {t - \delta} \right)\left\lbrack I\left( {t - \delta} \right) + U\left( {t - \delta} \right) \right\rbrack.$$$E\left( t \right)$ can be decoupled from the equations in the DDE system **SEIRU***δ*, since it can be obtained from $S\left( t \right)$, $I\left( t \right)$, and $U\left( t \right)$. The parameters and initial conditions of the **SEIRU***δ* model are given in [Table 2.1](#tbl2){ref-type="table"}, and a schematic diagram of the model is given in [Fig. 2.2](#fig2){ref-type="fig"}.

2.3. Data for the COVID-19 epidemic in China {#sec2.3}
--------------------------------------------

In our simulations of models **SEIRU** and **SEIRU***δ* for COVID-19 in mainland China, we will use the following data:

3. Estimation of the parameters and initial conditions {#sec3}
======================================================

The parameters *τ*, *ν*, $\nu_{1}$, $\nu_{2}$, *η*, *α*, *δ*, as well as the starting time $t_{0}$ and the initial conditions $S\left( t_{0} \right)$, $E\left( t_{0} \right)$, $I\left( t_{0} \right)$, $U\left( t_{0} \right)$, are uncertain. Our objective is to identify them from specific time data of reported symptomatic infectious cases. To identify the unreported asymptomatic infectious cases, we assume that the cumulative reported symptomatic infectious cases at time *t* consist of a constant fraction *f* of the total number of symptomatic infectious cases at time *t*. In other words, we assume that the removal rate *ν* of infectious asymptomatic cases $I\left( t \right)$ takes the following form: $\nu = \nu_{1} + \nu_{2}$, where $\nu_{1} = f\nu$ is the removal rate of reported symptomatic infectious individuals, and $\nu_{2} = \left( {1 - f} \right)\nu$ is the removal rate of unreported symptomatic infectious individuals due to all causes. The cumulative number of reported symptomatic infectious cases at time *t*, denoted by $CR\left( t \right)$, is$$CR\left( t \right) = \nu_{1}\int\limits_{t_{0}}^{t}I\left( s \right)ds.$$

Our method is the following: We assume that $CR\left( t \right)$ has the following form when the epidemic is in the early exponentially growing phase:$$CR\left( t \right) = \chi_{1}\text{exp}\left( {\chi_{2}t} \right) - \chi_{3}.$$

We evaluate . using the reported cases data. By using the method in Section [6.1](#sec6.1){ref-type="sec"} (Supplementary material), we estimate the starting time $t_{0}$ for the models from$$\left. CR\left( t_{0} \right) = 0\Leftrightarrow\chi_{1}exp\left( {\chi_{2}t_{0}} \right) - \chi_{3} = 0\ \ \Rightarrow\ \ t_{0} = \frac{1}{\chi_{2}}\left( {\text{ln}\left( \chi_{3} \right) - \text{ln}\left( \chi_{1} \right)} \right). \right.$$

We fix $S_{0} = 1.40005 \times 10^{9}$, which corresponds to the total population of mainland China. We assume that the variation in $S\left( t \right)$ is small during this exponentially growing phase. We fix $\nu,\eta,f,\alpha$. We assume that the transmission rate $\tau\left( t \right) \equiv \tau_{0}$ is constant during this exponentially growing phase. We identify $\tau_{0}$ from $\chi_{1},\chi_{2},\chi_{3}$ for each of the models **SEIRU** and **SEIRU***δ*.

3.1. Parameters and initial conditions for model **SEIRU** {#sec3.1}
----------------------------------------------------------

We fix the fraction $f = 0.8$ of symptomatic infectious cases that are reported. Thus, $80\text{\%}$ of infectious cases are reported. We assume $1/\nu$, the average time during which the patients are asymptomatic infectious is 5 days or 7 days. We assume that $1/\eta$, the average time during which a patient is symptomatic infectious, is 7 days. Since *f* is known, we obtain$$\nu_{1} = f\ \nu = 0.8/5\ \left( {\text{or~}0.8/7} \right)\ \text{~and~}\nu_{2} = \left( {1 - f} \right)\ \nu = 0.2/5\ \left( {\text{or~}0.2/7} \right).$$

From Section [6.1](#sec6.1){ref-type="sec"} (Supplementary material), we obtain$$E_{0} = \frac{\chi_{2} + \nu}{\alpha}I_{0},\ U_{0} = \frac{\nu_{2}}{\chi_{2} + \eta}I_{0},$$$$\tau_{0} = \frac{\left( {\chi_{2} + \alpha} \right)E_{0}}{S_{0}\left\lbrack I_{0} + U_{0} \right\rbrack} = \frac{\left( {\chi_{2} + \nu} \right)\left( {\chi_{2} + \alpha} \right)\left( {\chi_{2} + \eta} \right)}{\alpha S_{0}\left( {\chi_{2} + \eta + \nu_{2}} \right)}.$$

From Section [6.2](#sec6.2){ref-type="sec"} (Supplementary material), we obtain basic reproductive number $\mathcal{R}_{0}$ for model **SEIRU**$$\mathcal{R}_{0} = \frac{\left( {\chi_{2} + \nu} \right)\left( {\chi_{2} + \alpha} \right)\left( {\chi_{2} + \eta} \right)}{\alpha\nu\left( {\chi_{2} + \eta + \nu_{2}} \right)}\left( {1 + \frac{\left( {1 - f} \right)\ \nu}{\eta}} \right).$$

3.2. Parameters and initial conditions for model **SEIRU***δ* {#sec3.2}
-------------------------------------------------------------

The values of *f*, *ν*, and *η* are the same as for model **SEIRU**. From Section [6.3](#sec6.3){ref-type="sec"} (Supplementary material), we obtain$$S\left( {t_{0} + \theta} \right) = S_{0}\left( \theta \right) = S_{0},\ \theta \in \left\lbrack - \delta,0 \right\rbrack,$$$$I\left( {t_{0} + \theta} \right) = I_{0}\left( \theta \right) = \frac{\chi_{3}\chi_{2}}{f\ \nu}e^{\chi_{2}\theta},\ \theta \in \left\lbrack - \delta,0 \right\rbrack,$$$$U_{0}\left( {t_{0} + \theta} \right) = U_{0}\left( \theta \right) = \frac{\left( {1 - f} \right)\nu}{\eta + \chi_{2}}I_{0}\left( \theta \right),\ \theta \in \left\lbrack - \delta,0 \right\rbrack$$and$$\tau_{0} = \frac{\chi_{2} + \nu}{S_{0}}\frac{\eta + \chi_{2}}{\nu_{2} + \eta + \chi_{2}}e^{\chi_{2}\delta}.$$

From Section [6.4](#sec6.4){ref-type="sec"} (Supplementary material), we obtain the basic reproductive number $\mathcal{R}_{0}$ for model **SEIRU***δ*$$\mathcal{R}_{0} = \frac{\tau_{0}S_{0}}{\nu}\left( {1 + \frac{\nu_{2}}{\eta}} \right) = \frac{\chi_{2} + \nu}{\nu}\frac{\eta + \chi_{2}}{\nu_{2} + \eta + \chi_{2}}e^{\chi_{2}\delta}\left( {1 + \frac{\left( {1 - f} \right)\ \nu}{\eta}} \right).$$

4. Comparisons of the models with the data {#sec4}
==========================================

We use the data from [Table 2.3](#tbl2){ref-type="table"} to numerically simulate models **SEIRU** and **SEIRU***δ*.

4.1. Comparison of model **SEIRU** with data {#sec4.1}
--------------------------------------------

In [Fig. 4.1](#fig4){ref-type="fig"} and , we plot the graphs of $CR\left( t \right)$, $CU\left( t \right)$, $R\left( t \right)$, and $U\left( t \right)$ from the numerical simulation of model **SEIRU**. We use $\chi_{1} = 0.2254$, $\chi_{2} = 0.3762$, $\chi_{3} = 1$, $f = 0.8,\ \eta = 1/7,\ $ $t_{0} = 3.9607$, and $S_{0} = 1400050000$ in both [Fig. 4.1](#fig4){ref-type="fig"} and . We take $\nu = 1/5$ in [Fig. 4.1](#fig4){ref-type="fig"} and $\nu = 1/7$ in [Fig. 4.1](#fig4){ref-type="fig"}. We take four different values for *α*: $1/4,\ \ 1/2,\ \ 1,\ \ 3$ in both [Fig. 4.1](#fig4){ref-type="fig"} and [Fig. 4](#fig4){ref-type="fig"}. The value of *μ* is chosen so that the simulations align with the cumulative reported case data. In this way, we are able to predict the future values of the epidemic from early cumulative reported case data. We see from the simulations the following: for [Fig. 4.1](#fig4){ref-type="fig"}, with $\nu = 1/5$, the simulations are almost the same; for [Fig. 4.1](#fig4){ref-type="fig"}, with $\nu = 1/7$, the simulations are almost the same.Fig. 4Graphs of the reported cumulated symptomatic infectious individuals $\left. t\rightarrow CR\left( t \right) \right.$ (black solid line), unreported cumulated symptomatic infectious individuals $\left. t\rightarrow CU\left( t \right) \right.$ (green solid line), $\left. t\rightarrow U\left( t \right) \right.$ (blue solid line), and $\left. t\rightarrow R\left( t \right) \right.$ (red solid line). The red dots are the data of the reported cumulated confirmed cases for mainland China in [Table 2](#tbl2){ref-type="table"}. We use $\chi_{1} = 0.2254$, $\chi_{2} = 0.3762$, $\chi_{3} = 1$, $f = 0.8,\ \eta = 1/7,\ \nu = 1/5$, $t_{0} = 3.9607$, and $S_{0} = 1400050000$. (a) $\mu = 0.1276,\ \ 1/\alpha = 6\ hours$. (b) $\mu = 0.142,\ \ 1/\alpha = 12\ hours$. (c) $\mu = 0.166,\ \ 1/\alpha = 1\ day$. (d) $\mu = 0.25,\ \ 1/\alpha = 3\ days$.Fig. 4Fig. 5Graphs of the reported cumulated symptomatic infectious individuals $\left. t\rightarrow CR\left( t \right) \right.$ (black solid line), unreported cumulated symptomatic infectious individuals $\left. t\rightarrow CU\left( t \right) \right.$ (green solid line), $\left. t\rightarrow U\left( t \right) \right.$ (blue solid line), and $\left. t\rightarrow R\left( t \right) \right.$ (red solid line). The red dots are the data of the reported cumulated confirmed cases for mainland China in [Table 2](#tbl2){ref-type="table"}. We use $\chi_{1} = 0.2254$, $\chi_{2} = 0.3762$, $\chi_{3} = 1$, $f = 0.8,\ \eta = 1/7,\ \nu = 1/7$, and $S_{0} = 1400050000$. (a) $\mu = 0.1539,\ \ 1/\alpha = 6\ hours$. (b) $\mu = 0.169,\ \ 1/\alpha = 12\ hours$. (c) $\mu = 0.198,\ \ 1/\alpha = 1\ day$. (d) $\mu = 0.3,\ \ 1/\alpha = 3\ days$.Fig. 5Fig. 6Graphs of the reported cumulated symptomatic infectious individuals $\left. t\rightarrow CR\left( t \right) \right.$ (black solid line), unreported cumulated symptomatic infectious individuals $\left. t\rightarrow CU\left( t \right) \right.$ (green solid line), $\left. t\rightarrow U\left( t \right) \right.$ (blue solid line), and $\left. t\rightarrow R\left( t \right) \right.$ (red solid line). The red dots are the data of the reported cumulated confirmed cases for mainland China in [Table 2](#tbl2){ref-type="table"}. We use $\chi_{1} = 0.2254$, $\chi_{2} = 0.3762$, $\chi_{3} = 1$, $f = 0.8,\ \eta = 1/7,\ \nu = 1/5$, $t_{0} = 3.9607$, and $S_{0} = 1400050000$. (a) $\mu = 0.1273,\ \delta = 1/4$. (b) $\mu = 0.1432,\ \delta = 1/2$. (c) $\mu = 0.177,\ \delta = 1$. (d) $\mu = 0.373,\ \delta = 3$.Fig. 6Fig. 7Graphs of the reported cumulated symptomatic infectious individuals $\left. t\rightarrow CR\left( t \right) \right.$ (black solid line), unreported cumulated symptomatic infectious individuals $\left. t\rightarrow CU\left( t \right) \right.$ (green solid line), $\left. t\rightarrow U\left( t \right) \right.$ (blue solid line), and $\left. t\rightarrow R\left( t \right) \right.$ (red solid line). The red dots are the data of the reported cumulated confirmed cases for mainland China in [Table 2](#tbl2){ref-type="table"}. We use $\chi_{1} = 0.2254$, $\chi_{2} = 0.3762$, $\chi_{3} = 1$, $f = 0.8,\ \eta = 1/7,\ \nu = 1/7$, $t_{0} = 3.9607$, and $S_{0} = 1400050000$. (a) $\mu = 0.1515,\ \delta = 1/4$ day. (b) $\mu = 0.17,\ \delta = 1/2$ day. (c) $\mu = 0.2093,\ \delta = 1$ day. (d) $\mu = 0.454,\ \delta = 3$ days.Fig. 7

4.2. Comparison of model **SEIRU***δ* with data {#sec4.2}
-----------------------------------------------

In [Fig. 4.2](#fig4){ref-type="fig"} and , we plot the graphs of $CR\left( t \right)$, $CU\left( t \right)$, $R\left( t \right)$, and $U\left( t \right)$ from the numerical simulation of model **SEIRU***δ*. We use $\chi_{1} = 0.2254$, $\chi_{2} = 0.3762$, $\chi_{3} = 1$, $f = 0.8,\ \eta = 1/7,\ $ $t_{0} = 3.9607$, and $S_{0} = 1,400,050,000$ in both [Fig. 4.2](#fig4){ref-type="fig"} and . We take $\nu = 1/5$ in [Fig. 4.2](#fig4){ref-type="fig"} and $\nu = 1/7$ in [Fig. 4.2](#fig4){ref-type="fig"}. We take four different values for *δ*: $1/4,\ \ 1/2,\ \ 1,\ \ 3$ in both [Fig. 4.2](#fig4){ref-type="fig"} and [Fig. 4](#fig4){ref-type="fig"}. The value of *μ* is chosen so that the simulations align with the cumulative reported case data. In this way, we are able to predict the future values of the epidemic from early cumulative reported case data. We see from the simulations the following: for [Fig. 4.2](#fig4){ref-type="fig"}, with $\nu = 1/5$, the simulation for $\delta = 1/4$ is almost the same as $\delta = 1/2$, the simulations for $\delta = 1$ and $\delta = 3$ do not agree with the data, and thus, *δ* cannot be greater than 5 days; for [Fig. 4.2](#fig4){ref-type="fig"}, with $\nu = 1/7$, the simulations for $\delta = 1/4$, $\delta = 1/4$, and $\delta = 1$ are almost the same and for $\delta = 3$, the simulation does not agree with the data, and thus, *δ* cannot be greater than 7 days.

5. Discussion {#sec5}
=============

We have developed two models **SEIRU** and **SEIRU***δ* of the COVID-19 epidemic in China that incorporate key features of this epidemic: (1) the importance of implementation of major government public restrictions designed to mitigate the severity of the epidemic; (2) the importance of both reported and unreported cases in interpreting the number of reported cases; and (3) the importance of asymptomatic infectious cases in the disease transmission. The main difference from our previous papers ([@bib5]) and ([@bib4] Webb) is that we consider a latency period in the two models. In model **SEIRU**, an exposed class *E* is used to model latency. Newly infected individuals enter the class *E*, where they are neither symptomatic nor infectious. From this exposed class, noninfectious asymptomatic individuals enter an infectious asymptomatic class *I*. From *I*, asymptomatic infectious individuals enter a class *R* or *U* where they are symptomatic infectious, and later are reported *R* or unreported *U*. In model **SEIRU***δ* a time delay is used to model latency. Newly infected individuals enter the class *I* after a fixed time delay *δ*, and then proceed through classes *R* and *U*.

In order to compare the models **SEIRU** and **SEIRU***δ*, we use the Median of Absolute Deviation (MAD) as an indicator:$$MAD = \text{median}\left( {CR - CR_{Data}} \right),$$where $CR_{Data}$ is the vector of the cumulative number of reported cases from [Table 2.3](#tbl2){ref-type="table"}, while $CR$ is the vector of predicted cumulative number of reported cases of the model. The following table summaries the MAD of models **SEIRU** and **SEIRU***δ*.

From [Table 5](#tbl5){ref-type="table"}, it is evident that [Fig. 4.1(b)](#fig4){ref-type="fig"} is the best fit for model **SEIRU** (which corresponds to $1/\alpha = 12$hours) and [Fig. 4.2(a)](#fig4){ref-type="fig"} is the best fit for model **SEIRU***δ* (which corresponds to $\delta = 6$hours) (see [Table 4](#tbl4){ref-type="table"}). This mean that for both models, $\nu = 1/7$is better than $\nu = 1/5$. Furthermore, [Table 5](#tbl5){ref-type="table"} also indicates that model **SEIRU***δ* gives a better prediction than model **SEIRU**. We also deduce that the best exposure period varies between 6 h for model **SEIRU***δ* and 12 h for model **SEIRU**. Our finding is consistent with Zou ([@bib14]) where the high viral load observed for COVID-19 was used to explain that the transmission can occur at the early stage of the infection. This gives an explanation for the very short exposure period which give the best fit with data here. This also justifies the fact that in our previous articles ([@bib5]; [@bib4] Webb; [@bib7]) we neglected the exposure period.Table 4Predicted turning point and final size of the ODE model **SEIRU**. The turning point for $I\left( t \right)U\left( t \right)$. and $R\left( t \right)$is the time t at which these functions reach a maximum.Table 4FigureFinalFinal sizeFinal sizeTurning pointTurning pointsizeReportedUnreported**of**$R\left( t \right),U\left( t \right)$**of**$I\left( t \right)$[Fig. 4](#fig4){ref-type="fig"} (a)793466347715869day 39.4day 33.9[Fig. 4](#fig4){ref-type="fig"} (b)782416259315648day 39.0day 33.7[Fig. 4](#fig4){ref-type="fig"} (c)790366322915807day 38.9day 33.6[Fig. 4](#fig4){ref-type="fig"} (d)783636269115672day 38.8day 33.4[Fig. 5](#fig5){ref-type="fig"} (a)786886295015738day 39.4day 33.6[Fig. 5](#fig5){ref-type="fig"} (b)790976327815819day 39.2day 33.5[Fig. 5](#fig5){ref-type="fig"} (c)787546300315751day 38.9day 33.3[Fig. 5](#fig5){ref-type="fig"} (d)788056304415761day 38.9day 33.1Table 5Predicted turning point and final size of the DDE model **SEIRU**δ. The turning point for $I\left( t \right)U\left( t \right)$and $R\left( t \right)$is the time t at which these functions reach a maximum.Table 5FigureFinalFinal sizeFinal sizeTurning pointTurning pointsize**ReportedUnreported**of$R\left( t \right),U\left( t \right)$of$I\left( t \right)$[Fig. 6](#fig6){ref-type="fig"} (a)786336290715728day 39.4day 33.9[Fig. 6](#fig6){ref-type="fig"} (b)785626285015712day 39.1day 33.7[Fig. 6](#fig6){ref-type="fig"} (c)785906287215718day 38.6day 33.4[Fig. 6](#fig6){ref-type="fig"} (d)790116320915802day 37.1day 32.3[Fig. 7](#fig7){ref-type="fig"} (a)800436403516008day 39.6day 33.8[Fig. 7](#fig7){ref-type="fig"} (b)791396331215827day 39.3day 33.5[Fig. 7](#fig7){ref-type="fig"} (c)789346314715787day 38.7day 33.1[Fig. 7](#fig7){ref-type="fig"} (d)788396307115768day 37.0day 33.8

We summarize in the following tables the predicted turning point and final size, respectively, for models **SEIRU** and **SEIRU***δ*.

For our model without latency in ([@bib4] Webb), the turning point of the asymptomatic infectious cases $I\left( t \right)$ is approximately day 35 = February 4. The turning point of the reported cases $R\left( t \right)$ and the unreported cases $U\left( t \right)$ is approximately day 41 = February 10, and the final size of cumulative cases is approximately 79,400 with approximately 63,500 reported, 15,900 unreported. For the ODE model **SEIRU**, [Fig. 4.1](#fig4){ref-type="fig"} (b) (the best one according to MAD) predicts a turning point of the asymptomatic infectious cases $I\left( t \right)$ at approximately day 34 = February 3. The turning point of the reported cases $R\left( t \right)$ and the unreported cases $U\left( t \right)$ is approximately day 39 = February 8, and the final size of cumulative cases is approximately 63,278 reported, 15,819 unreported. For the DDE model **SEIRU***δ*, [Fig. 4.2](#fig4){ref-type="fig"} (a) (the best one according to MAD) predicts a turning point of the asymptomatic infectious cases $I\left( t \right)$ at approximately day 34 = February 3. The turning point of the reported cases $R\left( t \right)$ and the unreported cases $U\left( t \right)$ is approximately day 40 = February 9, and the final size of cumulative cases is approximately 64,035 reported 16,008 unreported.

Our analysis of the latency period for the COVID-19 epidemic in mainland China is applicable to COVID-19 epidemics in other regions.

6. Supplementary material {#sec6}
=========================

The part is devoted to the parameters estimation\'s of the models by assuming the reported cases data are exponentially growing. We assume that this exponential phase occurs before any public intervention. Therefore we assume that$$\tau\left( t \right) = \tau_{0}$$for both **SEIRU** and **SEIRU***δ* models.

6.1. Method to estimate the parameters and initial conditions of **SEIRU** from the number of reported cases {#sec6.1}
------------------------------------------------------------------------------------------------------------

In the following we fix $f,\nu,\eta,\alpha$.Step 1Since *f*, *α*, *η* and *ν* are fixed, we know that$$\nu_{1} = f\nu\ \text{~and~}\nu_{2} = \left( {1 - f} \right)\ \nu.$$Step 2By using equation (3.1) and (3.2) we obtain$$\left. CR\text{'}\left( t \right) = \nu_{1}I\left( t \right)\Leftrightarrow\chi_{1}\chi_{2}exp\left( {\chi_{2}t} \right) = \nu_{1}I\left( t \right) \right.$$and$$\frac{exp\left( {\chi_{2}t} \right)}{exp\left( {\chi_{2}t_{0}} \right)} = \frac{I\left( t \right)}{I\left( t_{0} \right)},$$and therefore$$I\left( t \right) = I_{0}exp\left( {\chi_{2}\left( {t - t_{0}} \right)} \right).$$

Moreover by using (6.2) at $t = t_{0}$$$I_{0} = \frac{\chi_{1}\chi_{2}exp\left( {\chi_{2}t_{0}} \right)}{f\ \nu} = \frac{\chi_{3}\chi_{2}}{f\ \nu}.$$Step 3In order to evaluated the parameters of the model we replace $S\left( t \right)$ by $S_{0} = 1.40005 \times 10^{9}$ in the right-hand side of (2.1) (which is equivalent to neglecting the variation of susceptibles due to the epidemic, which is consistent with the fact that $\left. t\rightarrow CR\left( t \right) \right.$ grows exponentially). Therefore, it remains to estimate $\tau_{0}$, $E_{0},$ and $U_{0}$ in the following system:$$\left\{ \begin{array}{l}
{E'\left( t \right) = \tau_{0}S_{0}\left\lbrack I\left( t \right) + U\left( t \right) \right\rbrack - \alpha E\left( t \right)} \\
{I'\left( t \right) = \alpha E\left( t \right) - \nu I\left( t \right)\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } \\
{U'\left( t \right) = \nu_{2}I\left( t \right) - \eta U\left( t \right).\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } \\
\end{array} \right.$$

By using the second equation we obtain$$E\left( t \right) = \frac{1}{\alpha}\left\lbrack I\text{'}\left( t \right) + \nu I\left( t \right) \right\rbrack,$$and therefore by using (6.2) we must have$$I\left( t \right) = I_{0}\text{exp}\left( {\chi_{2}\left( {t - t_{0}} \right)} \right)\text{~and~}E\left( t \right) = E_{0}\text{exp}\left( {\chi_{2}\left( {t - t_{0}} \right)} \right).$$

Then, by using the first equation we obtain$$U\left( t \right) = \frac{1}{\tau_{0}S_{0}}\left\lbrack E\text{'}\left( t \right) + \alpha E\left( t \right) \right\rbrack - I\left( t \right)$$and then$$U\left( t \right) = U_{0}\text{exp}\left( {\chi_{2}\left( {t - t_{0}} \right)} \right).$$

By substituting these expressions into (6.4), we obtain$$\left\{ \begin{matrix}
{\chi_{2}E_{0} = \tau_{0}S_{0}\left\lbrack I_{0} + U_{0} \right\rbrack - \alpha E_{0}} \\
{\chi_{2}I_{0} = \alpha E_{0} - \nu I_{0}\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } \\
{\chi_{2}U_{0} = \nu_{2}I_{0} - \eta U_{0}.\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } \\
\end{matrix} \right.$$Remark 6.1Here we fix $\tau_{0}$ in such a way that the value $\chi_{2}$ becomes the dominant eigenvalue of the linearized equation (6.5), and $\left( {E_{0},I_{0},U_{0}} \right)$ is the positve eigenvector associated to this dominant eigenvalue $\chi_{2}$. Thus, we apply implicitly the Perron-Frobenius theorem. Moreover the exponentially growing solution $\left( {E\left( t \right),I\left( t \right),U\left( t \right)} \right)$ that we consider (which is starting very close to $\left( 0,0,0 \right)$) follows the direction of the positive eigenvector associated with the dominant eigenvalue $\chi_{2}$.From the second and third equations of (6.5) we obtain$$E_{0} = \frac{\chi_{2} + \nu}{\alpha}I_{0},\ U_{0} = \frac{\nu_{2}}{\chi_{2} + \eta}I_{0},$$and by substituting these expressions into the first equation of (6.5) we obtain$$\tau_{0} = \frac{\left( {\chi_{2} + \alpha} \right)E_{0}}{S_{0}\left\lbrack I_{0} + U_{0} \right\rbrack} = \frac{\left( {\chi_{2} + \nu} \right)\left( {\chi_{2} + \alpha} \right)\left( {\chi_{2} + \eta} \right)}{\alpha S_{0}\left( {\chi_{2} + \eta + \nu_{2}} \right)}.$$

6.2. Computation of the basic reproductive number $\mathcal{R}_{0}$ of model **SEIRU** {#sec6.2}
--------------------------------------------------------------------------------------

In this section we apply results in Diekmann, Heesterbeek and Metz ([@bib2]) and Van den Driessche and Watmough ([@bib12]). The linearized equation of the infectious part of the system is given by$$\begin{cases}
{E\text{'}\left( t \right) = \tau S_{0}\left\lbrack I\left( t \right) + U\left( t \right) \right\rbrack - \alpha E\left( t \right)} & \\
{U\text{'}\left( t \right) = \nu_{2}I\left( t \right) - \eta U\left( t \right).} & \\
{I\text{'}\left( t \right) = \alpha E\left( t \right) - \nu I\left( t \right)} & \\
\end{cases}$$

The corresponding matrix is$$A = \begin{bmatrix}
{- \alpha} & {\tau S_{0}} & {\tau S_{0}} \\
0 & {- \eta} & \nu_{2} \\
\alpha & 0 & {- \nu} \\
\end{bmatrix}$$and the matrix *A* can be rewritten as$$A = V - S$$where$$V = \begin{bmatrix}
0 & {\tau S_{0}} & {\tau S_{0}} & \\
0 & 0 & \nu_{2} & \\
\alpha & 0 & 0 & \\
\end{bmatrix}\text{~and~}S = \begin{bmatrix}
\alpha & 0 & 0 & \\
0 & \eta & 0 & \\
0 & 0 & \nu & \\
\end{bmatrix}.$$

Therefore, the next generation matrix is$$VS^{- 1} = \begin{bmatrix}
0 & \frac{\tau S_{0}}{\eta} & \frac{\tau S_{0}}{\nu} & \\
0 & 0 & \frac{\nu_{2}}{\nu} & \\
1 & 0 & 0 & \\
\end{bmatrix}$$and we obtain that$$\mathcal{R}_{0} = \frac{\tau S_{0}}{\nu}\left( {1 + \frac{\nu_{2}}{\eta}} \right).$$

By using (6.6) we obtain$$\mathcal{R}_{0} = \frac{\left( {\chi_{2} + \nu} \right)\left( {\chi_{2} + \alpha} \right)\left( {\chi_{2} + \eta} \right)}{\alpha S_{0}\left( {\chi_{2} + \eta + \nu_{2}} \right)}\frac{S_{0}}{\nu}\left( {1 + \frac{\nu_{2}}{\eta}} \right)$$and by using $\nu_{2} = \left( {1 - f} \right)\ \nu$ we obtain$$\mathcal{R}_{0} = \frac{\left( {\chi_{2} + \nu} \right)\left( {\chi_{2} + \alpha} \right)\left( {\chi_{2} + \eta} \right)}{\alpha\nu\left( {\chi_{2} + \eta + \nu_{2}} \right)}\left( {1 + \frac{\left( {1 - f} \right)\ \nu}{\eta}} \right).$$

6.3. Method to estimate the parameters of model **SEIRU***δ* from the number of reported cases {#sec6.3}
----------------------------------------------------------------------------------------------

Step 1We have$$\nu_{1} = f\nu\ \text{~and~}\nu_{2} = \left( {1 - f} \right)\ \nu.$$Step 2By using equation [(3.2)](#fd3_2){ref-type="disp-formula"} we obtain$$\left. CR\text{'}\left( t \right) = \nu_{1}I\left( t \right)\Leftrightarrow\chi_{1}\chi_{2}exp\left( {\chi_{2}t} \right) = \nu_{1}I\left( t \right) \right.$$and$$\frac{exp\left( {\chi_{2}t} \right)}{exp\left( {\chi_{2}t_{0}} \right)} = \frac{I\left( t \right)}{I\left( t_{0} \right)},$$and therefore$$I\left( t \right) = I\left( t_{0} \right)exp\left( {\chi_{2}\left( {t - t_{0}} \right)} \right).$$

Moreover, by using (6.10) at $t = t_{0}$,$$I\left( t_{0} \right) = \frac{\chi_{1}\chi_{2}exp\left( {\chi_{2}t_{0}} \right)}{f\ \nu} = \frac{\chi_{3}\chi_{2}}{f\ \nu},\ \ \ \ U\left( t_{0} \right) = \frac{\nu_{2}}{\chi_{2} + \eta}\ I_{0}.$$Step 3In order to evaluate the parameters of the model **SEIRU***δ*, we replace $S\left( t \right)$ by $S_{0} = 1.40005 \times 10^{9}$ in the right-hand side of (2.4) (which is equivalent to neglecting the variation of susceptibles due to the epidemic, and is consistent with the fact that $\left. t\rightarrow CR\left( t \right) \right.$ grows exponentially). Therefore, it remains to estimate $\tau_{0}$ and *η* in the following system:$$\left\{ \begin{array}{l}
{I'\left( t \right) = \tau S_{0}\left\lbrack I\left( {t - \delta} \right) + U\left( {t - \delta} \right) \right\rbrack - \nu I\left( t \right)} \\
{U'\left( t \right) = \nu_{2}I\left( t \right) - \eta U\left( t \right).\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } \\
\end{array} \right.$$

By using the first equation we obtain$$U\left( t \right) = \frac{1}{\tau S_{0}}\left\lbrack I'\left( t \right) + \nu I\left( t \right) \right\rbrack - I\left( t \right),$$and therefore by using (6.11) we must have$$I\left( t \right) = I\left( t_{0} \right)\text{exp}\left( {\chi_{2}\left( {t - t_{0}} \right)} \right)\text{~and~}U\left( t \right) = U\left( t_{0} \right)\text{exp}\left( {\chi_{2}\left( {t - t_{0}} \right)} \right),$$so by substituting these expressions into (6.13) we obtain$$\left\{ \begin{array}{l}
{\chi_{2}I\left( t_{0} \right) = \tau S_{0}\left\lbrack I\left( t_{0} \right) + U\left( 0 \right) \right.} \\
{\chi_{2}U\left( t_{0} \right) = \nu_{2}I\left( t_{0} \right) - \eta U\left( t_{0} \right).} \\
\end{array} \right\}$$Remark 6.2Here we fix $\tau_{0}$ in such a way that the value $\chi_{2}$ becomes the dominant eigenvalue of the linearized equation (6.14) and $\left( {I\left( t_{0} \right),U\left( t_{0} \right)} \right)$ is the positve eigenvector associated to this dominant eigenvalue $\chi_{2}$. Thus, we apply implicitly the Perron-Frobenius theorem. Moreover the exponentially growing solution $\left( {I\left( t \right),U\left( t \right)} \right)$ that we consider (which is starting very close to $\left( 0,0 \right)$) follows the direction of the positive eigenvector associated with the dominant eigenvalue $\chi_{2}$.By dividing the first equation of (6.14) by $I\left( t_{0} \right)$ we obtain$$\chi_{2} = \tau S_{0}\left\lbrack 1 + \frac{U\left( t_{0} \right)}{I\left( t_{0} \right)} \right\rbrack e^{- \chi_{2}\delta} - \nu$$and hence$$\frac{U\left( t_{0} \right)}{I\left( t_{0} \right)} = \frac{\left( {\chi_{2} + \nu} \right)}{\tau S_{0}}e^{\chi_{2}\delta} - 1.$$By using the second equation of (6.14) we obtain$$\frac{U\left( t_{0} \right)}{I\left( t_{0} \right)} = \frac{\nu_{2}}{\eta + \chi_{2}}.$$By using (6.15) and (6.16) we obtain$$\tau = \frac{\left( {\chi_{2} + \nu} \right)}{S_{0}}e^{\chi_{2}\delta}\frac{\eta + \chi_{2}}{\nu_{2} + \eta + \chi_{2}}.$$By using (6.12) we compute$$U\left( t_{0} \right) = \frac{\nu_{2}}{\eta + \chi_{2}}I\left( t_{0} \right) = \frac{\left( {1 - f} \right)\nu}{\eta + \chi_{2}}I\left( t_{0} \right).$$

6.4. Computation of the basic reproductive number $\mathcal{R}_{0}$ of model **SEIRU***δ* {#sec6.4}
-----------------------------------------------------------------------------------------

The linearized equation of the infectious part of the system is given by$$\begin{cases}
{I'\left( t \right) = \tau S_{0}\left\lbrack I\left( {t - \delta} \right) + U\left( {t - \delta} \right) \right\rbrack - \nu I\left( t \right),} & \\
{U'\left( t \right) = \nu_{2}I\left( t \right) - \eta U\left( t \right).\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ } & \\
\end{cases}$$

We apply the results in Thieme ([@bib11]) to the linear operator $\left. A:D\left( A \right) \subset X\rightarrow X \right.$ where$$X = \mathbb{R}^{2} \times C\left( {\left\lbrack - \delta,0 \right\rbrack,\mathbb{R}^{2}} \right)$$$${A\begin{pmatrix}
0_{\mathbb{R}} \\
0_{\mathbb{R}} \\
I \\
U \\
\end{pmatrix}} = \begin{pmatrix}
{- I'\left( 0 \right) + \tau S_{0}\left\lbrack I\left( {- \delta} \right) + U\left( {- \delta} \right) \right\rbrack - \nu I\left( 0 \right)} \\
{- U'\left( 0 \right) + \nu_{2}I\left( 0 \right) - \eta U\left( 0 \right)} \\
{I'} \\
{U'} \\
\end{pmatrix}$$with$$D\left( A \right) = \left\{ 0_{\mathbb{R}} \right\}^{2} \times C^{1}\left( {\left\lbrack - \delta,0 \right\rbrack,\mathbb{R}^{2}} \right).$$

We split *A* into$${C\begin{pmatrix}
0_{\mathbb{R}} \\
0_{\mathbb{R}} \\
I \\
U \\
\end{pmatrix}} = \begin{pmatrix}
{\tau S_{0}\left\lbrack I\left( {- \delta} \right) + U\left( {- \delta} \right) \right\rbrack} \\
{\nu_{2}I\left( 0 \right)} \\
0_{C} \\
0_{C} \\
\end{pmatrix}$$$${B\begin{pmatrix}
0_{\mathbb{R}} \\
0_{\mathbb{R}} \\
I \\
U \\
\end{pmatrix}} = \begin{pmatrix}
{- I'\left( 0 \right) - \nu I\left( 0 \right)} \\
{- U'\left( 0 \right) - \eta U\left( 0 \right)} \\
{I'} \\
{U'} \\
\end{pmatrix}$$

By using Theorem 3.5 in ([@bib3]) we obtain that $- B$ is invertible and$${\left( {- B} \right)^{- 1}\begin{pmatrix}
\alpha \\
\beta \\
I \\
U \\
\end{pmatrix}} = \begin{pmatrix}
0 \\
0 \\
\widetilde{I} \\
\widetilde{U} \\
\end{pmatrix}$$where$$\begin{matrix}
{\widetilde{I}\left( \theta \right) = \nu^{- 1}\left\lbrack \alpha + I\left( 0 \right) \right\rbrack + \int_{\theta}^{0}I\left( \sigma \right)d\sigma} \\
{\widetilde{U}\left( \theta \right) = \eta^{- 1}\left\lbrack \beta + U\left( 0 \right) \right\rbrack + \int_{\theta}^{0}U\left( \sigma \right)d\sigma} \\
\end{matrix}$$

Thus we can compute$$C\left( {- B} \right)^{- 1}\begin{pmatrix}
\alpha \\
\beta \\
I \\
U \\
\end{pmatrix}$$and since the range of *C* is contained into $\mathbb{R}^{2} \times \left\{ 0_{C} \right\}^{2}$ it is sufficient to compute$${C\left( {- B} \right)^{- 1}\begin{pmatrix}
\alpha \\
\beta \\
0_{C} \\
0_{C} \\
\end{pmatrix}} = \begin{pmatrix}
{\tau S_{0}\left\lbrack \frac{\alpha}{\nu} + \frac{\beta}{\eta} \right\rbrack} \\
{\frac{\nu_{2}}{\nu}\alpha} \\
0_{C} \\
0_{C} \\
\end{pmatrix}.$$

Therefore, the next generation matrix is$$VS^{- 1} = \begin{bmatrix}
\frac{\tau S_{0}}{\nu} & \frac{\tau S_{0}}{\eta} \\
\frac{\nu_{2}}{\nu} & 0 \\
\end{bmatrix}$$which is a Leslie matrix, and the basic reproductive number $\mathcal{R}_{0}$ is$$\mathcal{R}_{0} = \frac{\tau S_{0}}{\nu}\left( {1 + \frac{\nu_{2}}{\eta}} \right).$$

By using (6.17) and $\nu_{2} = \left( {1 - f} \right)\ \nu$, we obtain$$\mathcal{R}_{0} = \frac{\chi_{2} + \nu}{\nu}\frac{\eta + \chi_{2}}{\nu_{2} + \eta + \chi_{2}}e^{\chi_{2}\delta}\left( {1 + \frac{\left( {1 - f} \right)\ \nu}{\eta}} \right).$$
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